Forecasting The Future: 16 Analyst Projections For Norwegian Cruise Line
Latest Ratings for NCLH Date Firm Action From To Mar 2022 Macquarie Maintains Outperform Feb 2022 Deutsche Bank Maintains Hold Feb 2022 Morgan Stanley Maintains Underweight View More Analyst Ratings for NCLH View the Latest Analyst Ratings read more
Crash-Proof Investing? New Innovator ETF Promises Downside Buffer
Innovator ETFs introduces ZJUN is a fund with a downside buffer and cap designed to protect investors from losses. read more
VanEck Launches GPZ ETF To Tap Into Private Market Boom
The VanEck Alternative Asset Manager ETF (GPZ) offers investors a new opportunity to access the private market boom. read more
Five Below Sees Strong Q1 As Analyst Flags Tariff Risk In Back Half Of 2025
Five Below (NASDAQ: FIVE) Q1 results and full-year guidance show strong merchandising, marketing, pricing, and in-store execution, offset by tariff pressures. Analyst maintains Market Perform rating with higher price target. Latest Ratings for FIVE Date Firm Action From To Mar 2022 UBS Upgrades Neutral Buy Jan 2022 Keybanc Upgrades Sector Weight Overweight Jan 2022 Truist…
MAIA Biotechnology’s Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients
MAIA posts 17.8-month median survival in NSCLC trial, nearly tripling standard care; long-term response seen in a chemo- and immunotherapy-resistant group. read more
Trump Says Musk Has ‘Trump Derangement Syndrome’ As Battle Over Bill Heats Up: ‘Had A Great Relationship… Don’t Know If We Will Anymore’
A public friendship between Donald Trump and Elon Musk could be over due to the Tesla CEO’s public opposition to the “Big Beautiful Bill.” read more